Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05654012 · ClinicalTrials.gov registry record · NA

Migraine in Adolescents

A NA study of Migraine, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT05654012 is a NA study of Migraine that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 250 participants, below the 356-participant average among 102 other Migraine trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05654012, a NA study of Migraine, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

Aim 1. To identify psychophysical and neural factors predicting migraine onset in adolescents Aim 2a. To determine hormonal, psychophysical, and neural changes associated with migraine onset. Aim 2b. To identify the temporal relationships between hormonal, psychophysical, and neural changes preceding vs. following migraine onset. Aim 3. To identify psychophysical and neural factors predicting migraine prognosis in adolescents with migraine.

Conditions Studied

Interventions

  • DEVICE MRI
  • DEVICE Thermal Stimuli
  • DEVICE Pressure stimuli
  • BEHAVIORAL Pain ratings
  • BEHAVIORAL Pressure pain thresholds (PPT)

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2023-06-01
Est. Completion 2030-03-15
Phase NA

What the Registry Record Tells You About NCT05654012

The ClinicalTrials.gov registry entry for NCT05654012 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 356-participant average among 102 other Migraine trials with a reported enrollment target (30% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 5 interventions - of which MRI is the first listed.

NCT05654012 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT05654012 about?

NCT05654012 is a clinical study titled "Migraine in Adolescents". Aim 1. To identify psychophysical and neural factors predicting migraine onset in adolescents Aim 2a. To determine hormonal, psychophysical, and neural changes associated with migraine onset. Aim 2b. To identify the temporal relationships between hormonal, psychophysical, and neural changes preced...

What is the current status of trial NCT05654012?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-06-01. Estimated completion is 2030-03-15.

What conditions does trial NCT05654012 study?

This clinical trial studies the following conditions: Migraine.

What interventions are being tested in trial NCT05654012?

The interventions under investigation include: MRI (DEVICE), Thermal Stimuli (DEVICE), Pressure stimuli (DEVICE), Pain ratings (BEHAVIORAL), Pressure pain thresholds (PPT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05654012?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05654012 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.